Sign inGet started

Canan John

Insider CIK 1374366 · ACST Director · REVG Director · MRK Sr.V-P Finc-Global Controller · TEX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
REVG REV Group, Inc. D To issuer2026-02-022026-02-022,105— $00SEC↗
REVG REV Group, Inc. D To issuer2026-02-022026-02-0263,285— $02,105SEC↗
TEX TEREX CORP A Award2026-02-022026-02-0462,076— $062,076SEC↗
TEX TEREX CORP A Award2026-02-022026-02-042,380— $064,456SEC↗
REVG REV Group, Inc. A Award2025-12-032025-12-052,105— $065,390SEC↗
REVG REV Group, Inc. A Award2024-12-052024-12-093,611— $063,285SEC↗
REVG REV Group, Inc. A Award2023-12-082023-12-127,084— $059,674SEC↗
REVG REV Group, Inc. A Award2022-12-082022-12-127,960— $052,590SEC↗
ACST Acasti Pharma Inc. A Award deriv2022-09-282022-09-3045,000— $045,000SEC↗
REVG REV Group, Inc. A Award2021-12-092021-12-135,945— $044,630SEC↗
ACST Acasti Pharma Inc. A Award deriv2021-11-122021-11-1642,100— $042,100SEC↗
REVG REV Group, Inc. A Award2020-12-112020-12-1510,584— $038,685SEC↗
REVG REV Group, Inc. A Award2019-12-182019-12-207,797— $025,299SEC↗
REVG REV Group, Inc. A Award2019-01-092019-01-1111,099— $017,502SEC↗
REVG REV Group, Inc. P Buy2018-06-252018-06-27200$16.05 $3.2K6,363SEC↗
REVG REV Group, Inc. P Buy2018-06-252018-06-274,440$16.04 $71.2K5,763SEC↗
REVG REV Group, Inc. P Buy2018-06-252018-06-27400$16.06 $6.4K6,163SEC↗
REVG REV Group, Inc. A Award2018-02-062020-01-172,842— $028,101SEC↗
REVG REV Group, Inc. A Award2017-01-262017-01-301,363— $01,363SEC↗
MRK Merck & Co. Inc. A Award2014-02-242014-02-262,913$56.18 $163.7K13,610SEC↗
MRK Merck & Co. Inc. M Exercise deriv2014-02-112014-02-1110,000— $00SEC↗
MRK Merck & Co. Inc. S Sale2014-02-112014-02-1110,000$55.70 $557.0K10,697SEC↗
MRK Merck & Co. Inc. M Exercise2014-02-112014-02-1110,000$48.24 $482.4K20,697SEC↗
MRK Merck & Co. Inc. M Exercise deriv2013-05-072013-05-084,479$44.98 $201.5K0SEC↗
MRK Merck & Co. Inc. F Tax w/h2013-05-072013-05-081,669$44.98 $75.1K10,550SEC↗
MRK Merck & Co. Inc. M Exercise2013-05-072013-05-084,479— $012,219SEC↗
MRK Merck & Co. Inc. A Award deriv2013-05-062013-05-084,002— $04,002SEC↗
MRK Merck & Co. Inc. A Award deriv2013-05-062013-05-0838,647— $038,647SEC↗
MRK Merck & Co. Inc. A Award2013-02-252013-02-272,657$42.52 $113.0K7,715SEC↗
MRK Merck & Co. Inc. S Sale2012-08-012012-08-0230,500$44.29 $1.35M5,058SEC↗
MRK Merck & Co. Inc. M Exercise deriv2012-07-242012-07-269,681$43.27 $418.9K0SEC↗
MRK Merck & Co. Inc. M Exercise2012-07-242012-07-269,681— $039,078SEC↗
MRK Merck & Co. Inc. F Tax w/h2012-07-242012-07-263,520$43.27 $152.3K35,558SEC↗
MRK Merck & Co. Inc. A Award deriv2012-05-022012-05-0443,876— $043,876SEC↗
MRK Merck & Co. Inc. A Award deriv2012-05-022012-05-044,581— $04,581SEC↗
MRK Merck & Co. Inc. M Exercise deriv2012-04-242012-04-265,775$38.27 $221.0K0SEC↗
MRK Merck & Co. Inc. F Tax w/h2012-04-242012-04-262,100$38.27 $80.4K29,106SEC↗
MRK Merck & Co. Inc. M Exercise2012-04-242012-04-265,775— $031,206SEC↗
MRK Merck & Co. Inc. A Award2012-02-282012-03-014,268$38.38 $163.8K25,171SEC↗